Analyze Diet
American journal of veterinary research2012; 73(5); 628-633; doi: 10.2460/ajvr.73.5.628

Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses.

Abstract: To assess clinical, radiographic, histologic, and biochemical effects of sodium pentosan polysulfate (NaPPS) administered IM for treatment of experimentally induced osteoarthritis in horses. Methods: 18 horses. Methods: Osteoarthritis was induced arthroscopically in 1 middle carpal joint of all horses. Nine horses received NaPPS (3 mg/kg, IM) on study days 15, 22, 29, and 36. Nine control horses received the same volume of saline (0.9% NaCl) solution IM on study days 15, 22, 29, and 36. Clinical, radiographic, gross, histologic, histochemical, and biochemical findings as well as findings of synovial fluid analysis were evaluated. Results: No adverse treatment-related events were detected. Induced osteoarthritis caused a substantial increase in lameness, response to flexion, joint effusion, radiographic findings, synovial membrane inflammation, and articular cartilage fibrillation. Articular cartilage fibrillation was substantially reduced by NaPPS treatment, and concentrations of chondroitin sulfate 846 epitope were significantly increased in the synovial fluid of osteoarthritic and non-osteoarthritic joints of treated horses. Conclusions: Results indicated that NaPPS has some beneficial disease-modifying effects and may be a therapeutic option for osteoarthritis in horses.
Publication Date: 2012-04-27 PubMed ID: 22533393DOI: 10.2460/ajvr.73.5.628Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article abstract presents the findings from a study that evaluated the effectiveness of using Sodium Pentosan Polysulfate, a medication, to treat osteoarthritis in horses. The experiment concluded that Sodium Pentosan Polysulfate has potential beneficial effects for treating osteoarthritis in horses, and it could be considered as a therapeutic option since it showed a reduction of symptoms and no adverse effects.

Research Method

  • The study included 18 horses, all of which were found to have experimentally induced osteoarthritis on one of their middle carpal joints.
  • The horses were divided into two groups. One group of 9 horses received Sodium Pentosan Polysulfate intramuscularly on specific study days (15, 22, 29, and 36), while the control group received a saline solution on the same days and via the same method.
  • The researchers used clinical, radiographic, gross, histologic, histochemical, and biochemical findings to assess the effects of the treatment. Synovial fluid analysis was also conducted to enhance the evaluation.

Results of The Study

  • The study reported no adverse events related to the treatment. This suggests that Sodium Pentosan Polysulfate is a safe option to use for horses suffering from osteoarthritis.
  • Osteoarthritis led to an increased level of lameness, joint effusion, reaction to flexion, and changes in radiographic and synovial membrane inflammation. Furthermore, osteoarthritis resulted in articular cartilage fibrillation.
  • Upon the administration of Sodium Pentosan Polysulfate, there was a significant decrease in articular cartilage fibrillation. This shows that the drug can potentially inhibit the progression of the disease.
  • The concentration of chondroitin sulfate 846 epitope in the synovial fluid of both healthy and osteoarthritic joints of treated horses significantly increased. Given that this biochemical molecule promotes joint health, its increased concentration suggests potential curative effects of Sodium Pentosan Polysulfate.

Conclusions

  • The research findings concluded that Sodium Pentosan Polysulfate could have disease-altering benefits for managing osteoarthritis in horses.
  • With no adverse events reported and some of the symptoms of osteoarthritis improving following the treatment, the drug presents a promising therapeutic option for managing the disease.

Cite This Article

APA
McIlwraith CW, Frisbie DD, Kawcak CE. (2012). Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses. Am J Vet Res, 73(5), 628-633. https://doi.org/10.2460/ajvr.73.5.628

Publication

ISSN: 1943-5681
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 73
Issue: 5
Pages: 628-633

Researcher Affiliations

McIlwraith, C Wayne
  • Gail Holmes Equine Orthopaedic Research Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA. wayne.mcilwraith@colostate.edu
Frisbie, David D
    Kawcak, Christopher E

      MeSH Terms

      • Animals
      • Arthrography / veterinary
      • Arthroscopy / adverse effects
      • Arthroscopy / veterinary
      • Enzyme Inhibitors / administration & dosage
      • Enzyme Inhibitors / therapeutic use
      • Horse Diseases / drug therapy
      • Horse Diseases / pathology
      • Horses
      • Injections, Intramuscular / veterinary
      • Joint Diseases / drug therapy
      • Joint Diseases / pathology
      • Joint Diseases / veterinary
      • Osteoarthritis / drug therapy
      • Osteoarthritis / pathology
      • Osteoarthritis / veterinary
      • Pentosan Sulfuric Polyester / administration & dosage
      • Pentosan Sulfuric Polyester / therapeutic use

      Citations

      This article has been cited 7 times.
      1. Wang Y, Sunaga T, Mwale C, Akaraphutiporn E, Kim S, Okumura M. Pentosan polysulfate sodium promotes redifferentiation to the original phenotype in micromass-cultured canine articular chondrocytes and exerts molecular weight-dependent effects.. J Vet Med Sci 2023 Jun 14;85(6):680-690.
        doi: 10.1292/jvms.22-0567pubmed: 37150611google scholar: lookup
      2. Wijekoon S, Tsogbadrakh M, Sunaga T, Wang Y, Mwale C, Kim S, Alimaa D, Okumura M. Pentosan polysulfate regulates hepcidin expression in native Mongolian horses.. J Vet Med Sci 2022 Oct 7;84(10):1437-1441.
        doi: 10.1292/jvms.22-0113pubmed: 36047165google scholar: lookup
      3. Andersen C, Jacobsen S, Walters M, Lindegaard C. A detailed macroscopic scoring system for experimental post-traumatic Osteoarthritis in the equine middle carpal joint.. BMC Res Notes 2022 Jun 27;15(1):226.
        doi: 10.1186/s13104-022-06116-xpubmed: 35761416google scholar: lookup
      4. Braucke AFGV, Frederiksen NL, Berg LC, Aarsvold S, Müller FC, Boesen MP, Lindegaard C. Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue.. Animals (Basel) 2020 Mar 18;10(3).
        doi: 10.3390/ani10030506pubmed: 32197454google scholar: lookup
      5. Frohbergh M, Ge Y, Meng F, Karabul N, Solyom A, Lai A, Iatridis J, Schuchman EH, Simonaro CM. Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment.. PLoS One 2014;9(6):e100882.
        doi: 10.1371/journal.pone.0100882pubmed: 24964042google scholar: lookup
      6. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res 2012 Nov;1(11):297-309.
        doi: 10.1302/2046-3758.111.2000132pubmed: 23610661google scholar: lookup
      7. Schuchman EH, Ge Y, Lai A, Borisov Y, Faillace M, Eliyahu E, He X, Iatridis J, Vlassara H, Striker G, Simonaro CM. Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.. PLoS One 2013;8(1):e54459.
        doi: 10.1371/journal.pone.0054459pubmed: 23365668google scholar: lookup